Dr. Daniel German Maluf, MD

Dr. Maluf practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Maluf's NPI, 1447336102, was assigned on October 27, 2006. Dr. Maluf graduated from UVA School of Medicine in 1998. Dr. Maluf's Maryland license number on file is D89838.

Dr. Maluf's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Maluf's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Maluf to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maluf practices. Vendor and product names are available with a free account.

Transplant surgery is Dr. Maluf's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dmand AI has Dr. Maluf's licenses on file in 3 states: Maryland, Virginia and Tennessee.

Dmand AI lists groin hernia surgery and kidney transplant among the conditions Dr. Maluf treats.

CMS data shows 215 Medicare services from Dr. Maluf across 3 procedure codes in 2024, for 69 Medicare patients. Medicare paid $48,137 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Maluf in 2024. The largest group is under 65, with 43 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 41% are also on Medicaid. Their average risk score is 9.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maluf's median patient age at 62, with 38% women.

In 2020, Dr. Maluf wrote 31 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $2,708 in total drug cost. In 2019, CMS named 78 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Maluf for performance year 2024, reported as part of a group. Dr. Maluf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 134 papers to Dr. Maluf, published from 2007 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Liver Transplantation, Kidney Transplantation and Graft Rejection. Dr. Maluf has published most often in Transplantation. Dr. Maluf's most frequent co-authors are Robert A. Fisher, MD, James D. Eason, MD and Lorenzo G. Gallon, MD.

Dmand AI links Dr. Maluf to 3 clinical trials. Conditions studied include Liver Cirrhosis and Hepatitis C.

CMS Open Payments shows 11 general payments to Dr. Maluf from 6 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 76% of the total. Novartis Pharma AG paid the most, $1,706.

Dmand AI lists 1 award for Dr. Maluf, most recently CMS Stage 1 EHR in 2014. Dr. Maluf serves on Business Excecutive Committee International Liver Transplant Society.

Dr. Maluf graduated from UVA School of Medicine in 1998.

Dr. Maluf is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.